Delivery Order SPE2DB20D2014-SPE2DB25FB25P

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,186.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of BREZTRI AEROSPHERE INHALER 10.7GM, a medical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,414.42, is for the delivery of BREZTRI AEROSPHERE INHALER 10.7GM, a pharmaceutical product. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with a total value of up to $999,999,999.00, which runs through November 2026. This IDC serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,828.32, is for the delivery of the BREZTRI AEROSPHERE INHALER 10.7GM medical supply. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,766.96 delivery order contract is for the supply of BREZTRI AEROSPHERE INHALER 10.7GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of July 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,708.21 firm fixed-price delivery order is for the BREZTRI AEROSPHERE INHALER 10.7GM medical product. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,502.51, is for the delivery of a pharmaceutical product, the BREZTRI AEROSPHERE INHALER 10.7GM. This appears to be a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,950.21 firm fixed price delivery order is for the procurement of BREZTRI AEROSPHERE INHALER 10.7GM, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with a ceiling value of $1,440.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order without a set-aside designation, indicating open competition. It covers the supply of BREZTRI AEROSPHERE INHALER 10.7GM, a medical product, with a period of performance through February 20, 2025. Amerisourcebergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp. is a delivery order from the Defense Logistics Agency (DLA) worth $9,822.41. The contract is for the supply of BREZTRI AEROSPHERE INHALER 10.7GM, a pharmaceutical product. The contract is a firm fixed-price agreement with a completion date of December 6, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly...
This federal contract award, valued at $1,421.58, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BREZTRI AEROSPHERE INHALER 10.7GM, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB25P
    Delivery Order

This federal contract award, valued at $9,618.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREZTRI AEROSPHERE INHALER 10.7GM, a medical product, with a completion date of March 7, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no major subcontractors are mentioned. The DLA, a defense agency, is the funding agency for this contract, which aligns with the company's focus on providing medical products and supplies to military and veterans' healthcare systems.

Generated 6/5/25, 10:04 AM